Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-28

Clinical Trial Update: Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial investigates induced pluripotent stem cell-derived small extracellular vesicles for improving neurological function and cognitive impairment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Induced pluripotent stem cell-derived small extracellular vesicles

Snippet

Sponsor: Hongmei Wang | Conditions: Cognitive Impairment | Phase 1, Phase 2 | Status: RECRUITING